Heron Therapeutics
HRTX
HRTX
151 hedge funds and large institutions have $192M invested in Heron Therapeutics in 2023 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 45 increasing their positions, 38 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more funds holding
Funds holding: 141 → 151 (+10)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8.86% less ownership
Funds ownership: 84.11% → 75.24% (-8.9%)
Holders
151
Holding in Top 10
3
Calls
$2.19M
Puts
$158K
Top Buyers
| 1 | +$8.71M | |
| 2 | +$5.38M | |
| 3 | +$2.71M | |
| 4 |
MAM
Monaco Asset Management
Monaco
|
+$2.6M |
| 5 |
CPC
Congress Park Capital
Saratoga Springs,
New York
|
+$2.06M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$8.38M | |
| 3 | -$4.88M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.15M |
| 5 |
BlackRock
New York
|
-$1.64M |